Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Ari Raphael (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation
Introduction
Dr. Ari Raphael, MD, is a highly experienced clinical oncologist based in Tel Aviv, Israel. With over 15 years of professional practice, Dr. Raphael specializes in the diagnosis and treatment of various cancers, providing state-of-the-art oncological care at Sourasky Medical Center (Ichilov). His expertise lies in personalized cancer therapies, with a focus on combining cutting-edge clinical research and compassionate patient care.
- Full name: Dr. Ari Raphael, MD
- Location: Sourasky Medical Center (Ichilov), Tel Aviv, Israel
- Specialty: Clinical Oncology
- Experience: Over 15 years in oncology and cancer treatment
Educational Background
Dr. Ari Raphael’s academic journey reflects his dedication to excellence in oncology. He completed his medical degree and specialized oncology training with a focus on advanced cancer treatments.
- Medical School: Graduated from a top medical university in Israel (details not publicly disclosed)
- Oncology Residency: Completed residency in clinical oncology at a leading Israeli medical center
- Fellowships: Advanced oncology training with international exposure to latest cancer treatment protocols
- Honors: Recognized for academic and clinical excellence during training phases
Professional Experience
Dr. Raphael currently serves as a leading clinical oncologist at Sourasky Medical Center (Ichilov) in Tel Aviv, one of Israel’s premier hospitals. His clinical experience encompasses a broad spectrum of cancer types and treatment modalities.
- Current position: Senior Clinical Oncologist, Sourasky Medical Center (Ichilov), Tel Aviv
- Previous roles: Experience in oncology departments at multiple leading hospitals and cancer centers
- Procedures: Has overseen and managed hundreds of chemotherapy and immunotherapy treatment plans
- Leadership: Active mentor for junior oncologists and medical residents in clinical oncology
Academic Contributions
Dr. Raphael is actively involved in academic oncology through teaching, research, and conference participation.
- Teaching: Regular instructor for medical students and oncology residents at Sourasky Medical Center
- Lectures: Presenter at national and international oncology conferences
- Research interests: Focus on immunotherapy, personalized cancer treatment, and clinical trial development
- Mentorship: Guides young oncologists in research methodologies and clinical skills development
Areas of Expertise
Dr. Ari Raphael’s clinical expertise covers a wide range of oncological conditions, providing patients with comprehensive and individualized care plans.
- Treatment of solid tumors such as lung, breast, colorectal, and prostate cancers
- Management of hematologic malignancies including lymphomas and leukemias
- Personalized chemotherapy and immunotherapy protocols
- Supportive care addressing treatment side effects and quality of life issues
- Coordination of multidisciplinary cancer care teams
Publications and Research
Dr. Raphael has contributed to the oncology field through multiple peer-reviewed articles and clinical research projects, advancing knowledge in cancer treatment.
Selected publications:
- Author and co-author of research articles on immunotherapy outcomes in lung cancer patients
- Contributor to book chapters on chemotherapy advancements and patient management strategies
- Active participant in clinical trials investigating novel targeted therapies
Patient Care Philosophy
Dr. Raphael believes that effective cancer care requires more than medical treatment; it demands empathy, clear communication, and patient empowerment.
- Emphasizes open dialogue and patient education to ensure informed decision-making
- Advocates for culturally sensitive care, tailored to the needs of international patients
- Available for online consultations and pre-treatment counseling for global patients
- Focuses on holistic care to support both physical and emotional well-being
- Known for high patient satisfaction and long-term treatment success stories
Professional Affiliations
Dr. Ari Raphael maintains active membership in several prestigious professional organizations, reflecting his commitment to ongoing education and quality care.
- Israeli Society of Clinical Oncology and Radiotherapy
- European Society for Medical Oncology (ESMO)
- Member of national medical boards and certification committees in Israel
- Licensed and board-certified oncologist in Israel
FAQs
- Is Dr. Ari Raphael board-certified?
- Yes, Dr. Raphael is board-certified in clinical oncology in Israel.
- What types of treatments does he provide?
- He offers chemotherapy, immunotherapy, targeted therapy, and supportive cancer care for various types of cancers.
- Does Dr. Raphael treat international patients?
- Yes, he is experienced in managing international patients and offers online pre-consultations to accommodate their needs.
- How long is the typical hospital stay for treatment?
- Most cancer treatments under Dr. Raphael’s care are outpatient; hospital stays depend on the treatment type and patient condition.
- What languages does Dr. Ari Raphael speak?
- Dr. Raphael communicates fluently in Hebrew and English, facilitating care for local and international patients.
- Does Dr. Raphael participate in clinical research?
- Yes, he is actively involved in clinical trials and oncology research to provide patients access to innovative therapies.
- Can patients schedule online consultations?
- Yes, Dr. Raphael offers online consultations for initial evaluations and treatment planning for patients abroad.
Oncologist, Specialist in medical oncology – breast cancer.
Oncologist, Specialist in medical oncology – lung cancer.
Director of oncology day hospitalization,
Senior physician in the breast cancer unit,
Researcher in the cancer clinical research unit, molecular clinic.
Decoding Genomic Sequencing (NGS).
Senior researcher in phase I-II studies including intratumoral injections.
Translational research – TCR at Bar-Ilan University and ctDNA at the Institute of Pathology
Patient reviews
Patient reviews




